Feedback / Questions
BNL-101 - Bionaut
https://www.prnewswire.com/news-releases/fda-grants-bionaut-labs-orphan-drug-designation-to-bnl-101-for-the-treatment-of-malignant-gliomas-in-pediatric-and-adult-patients-301317815.html
 
Jun 23, 2021
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious